|
AU2018282735A1
|
|
Methods for the treatment of leptomeningeal disease
|
|
US2018318421A1
|
|
Methods for the treatment of recurrent glioblastoma (RGBM)
|
|
US2006246016A1
|
|
Toothpaste containing anticancer agents
|
|
US2006205818A1
|
|
Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives
|
|
WO2006047125A2
|
|
Method for immobilizing molecular probes to a semiconductor oxide surface
|
|
WO2005103066A1
|
|
Method for attaching molecular probes to a solid support
|
|
US7087219B2
|
|
Toothpaste containing anticancer agents
|
|
PL353656A1
|
|
Preparation containing amino acids and riboflavin, useful in reducing toxic effects of a treatment by means of cytotoxic drugs
|
|
US6372938B1
|
|
Synthesis of 4-phenylbutyric acid
|
|
US6987131B1
|
|
Phenylacetic acid compositions for treating or preventing hypercholesterolemia
|
|
WO0030627A2
|
|
Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
|
|
CN1319010A
|
|
Treatment regimen for administration of phenylacetylgluta-mine, phenylacetylisoglutamize, and/or phenylacetate
|
|
EP0906088A1
|
|
Liposomal antineoplaston therapies with markedly improved antineoplastic activity
|
|
AU1777595A
|
|
Methods for treating neurofibromatosis
|
|
WO9325201A1
|
|
Compositions and methods for treating autoimmune diseases
|
|
US5244922A
|
|
Methods for treating viral infections
|
|
US5254587A
|
|
Methods for treating AIDS
|
|
US5116622A
|
|
Methods for treating parkinson's disease
|
|
US5089508A
|
|
Methods for treating aids
|
|
US4918193A
|
|
Methods for preparing 3-[N-phenyl-acetylaminopiperidine]-2,6-dion
|
